- Home
- WFRD vs PCVX Comparison
WFRD vs PCVX Comparison
Compare WFRD & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WFRD
- PCVX
- Stock Information
- Founded
- WFRD 1941
- PCVX 2013
- Country
- WFRD United States
- PCVX United States
- Employees
- WFRD N/A
- PCVX N/A
- Industry
- WFRD Metal Fabrications
- PCVX Biotechnology: Pharmaceutical Preparations
- Sector
- WFRD Industrials
- PCVX Health Care
- Exchange
- WFRD Nasdaq
- PCVX Nasdaq
- Market Cap
- WFRD 7.9B
- PCVX 14.7B
- IPO Year
- WFRD N/A
- PCVX 2020
- Fundamental
- Price
- WFRD $79.03
- PCVX $106.97
- Analyst Decision
- WFRD Strong Buy
- PCVX Strong Buy
- Analyst Count
- WFRD 9
- PCVX 7
- Target Price
- WFRD $146.00
- PCVX $147.50
- AVG Volume (30 Days)
- WFRD 1.1M
- PCVX 636.4K
- Earning Date
- WFRD 10-22-2024
- PCVX 11-04-2024
- Dividend Yield
- WFRD 1.26%
- PCVX N/A
- EPS Growth
- WFRD 51.37
- PCVX N/A
- EPS
- WFRD 7.14
- PCVX N/A
- Revenue
- WFRD $5,534,000,000.00
- PCVX N/A
- Revenue This Year
- WFRD $13.40
- PCVX N/A
- Revenue Next Year
- WFRD $7.20
- PCVX N/A
- P/E Ratio
- WFRD $11.09
- PCVX N/A
- Revenue Growth
- WFRD 11.08
- PCVX N/A
- 52 Week Low
- WFRD $77.29
- PCVX $46.16
- 52 Week High
- WFRD $135.00
- PCVX $121.06
- Technical
- Relative Strength Index (RSI)
- WFRD 32.02
- PCVX 39.76
- Support Level
- WFRD $77.29
- PCVX $102.84
- Resistance Level
- WFRD $80.60
- PCVX $115.56
- Average True Range (ATR)
- WFRD 3.06
- PCVX 3.32
- MACD
- WFRD -0.76
- PCVX -1.41
- Stochastic Oscillator
- WFRD 8.12
- PCVX 21.55
About WFRD Weatherford International plc
Weatherford International provides diversified oilfield services across international markets for an array of oilfield types. The firm is a global market leader in artificial lift and tubular running services. Other key product lines include cementing products, directional drilling, and wireline evaluation.
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a vaccine company seeking to improve global health by developing novel vaccines to treat patients suffering from the most common and deadly diseases. Its product comprises. of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-24, VAX-A1, and VAX-PG.